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ABSTRACT
Traditional dietary management of chronic kidney disease (CKD)
focuses on the quantity within the diet of energy and protein, and
the restriction of single micronutrients, with little mention of diet-
ary quality. Dietary patterns that are more plant-based, lower
in meat (including processed meat), sodium and refined sugar,
and have a higher content of grains and fibres are now included in
multiple clinical guidelines for chronic disease prevention. The
Mediterranean diet (MD) has been associated with reduced cardi-
ovascular disease incidence in both observational and interven-
tional studies. A wealth of evidence linksMDwith other beneficial
effects on chronic diseases such as diabetes, obesity or cognitive
health. This review examines each constituent of the classical MD
and evaluates their suitability for the management of patients with
CKD. We also evaluate the potential hyperkalaemia risk of
increasing fruit and vegetable intake. Overall, a decrease in net
endogenous acid production and increase in fibre may lead to a
better control of metabolic acidosis. This, together with other
putative favourable effects of MD on endothelial function, inflam-
mation, lipid profile and blood pressure, provide mechanistic
pathways to explain the observed reduced renal function decline
and improved survival in CKD patients adhering to anMD.
Keywords: kidney disease, Mediterranean diet, nutrition, veg-
etarian diet
INTRODUCTION
The potential role of a healthy diet is far more complex than
delivering a combination of nutrients. Public health recommen-
dations for prevention of cardiovascular disease (CVD) have,
for instance, moved from a single-nutrient focus to whole foods
and dietary patterns [1], which are more easily translated into
dietary recommendations. Patients with chronic kidney disease
(CKD) are at high risk of CVD complications, contributing to
the most common cause of death. Traditional dietary manage-
ment of CKD focuses predominantly on the quantity within the
diet of energy and protein, and the restriction of single micro-
nutrients, with little mention of dietary quality. Emphasis on
restriction of sodium, potassium and phosphorus in CKD may
possibly compromise overall diet quality [2].
Fruit and vegetable-rich diets such as the Mediterranean diet
(MD) are recommended for primary and secondary disease pre-
vention. Emerging evidence in patients with CKD suggests these
diets may be helpful to delay progression and prevent complica-
tions [3]. Reluctance to recommend an MD to the CKD patient
may arise when some of the typical components of the MD pyra-
mid conflict with the traditional dietary restrictions of CKD. The
European Renal Nutrition (ERN) Working Group of the
European Renal Association–European Dialysis Transplant
Association (ERA-EDTA) aims, with this review, to summarize
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arguments in favour of and against adopting the MD as a healthy
dietary pattern and lifestyle for the CKD population.
THE MD: A MODEL OF CARDIOPROTECTION
Features
The traditional Mediterranean dietary pattern has the fol-
lowing characteristics [4]:
• High consumption of fruits, vegetables, bread and whole-
grain cereals, potatoes, beans, nuts and seeds
• Extra virgin olive oil (cold pressed) as an important
monounsaturated fat source
• Dairy products, fish and poultry are consumed in low-to-
moderate amounts
• Eggs are consumed zero to four times a week
• Sweets are seldom consumed
• Red meat is eaten less often and in connection with spe-
cial occasions
• Wine is consumed in low-to-moderate amounts, during
meals
Despite some agreement on the characteristics of an MD,
there is wide variation on the number and proportion of serv-
ings per week for theMD components as it appears in the litera-
ture. To account for this variability, estimates were averaged
from literature review resulting in the diet pyramid (Figure 1),
often recommended in public health prevention programmes.
We acknowledge that this ‘traditional’ MD pyramid is not nec-
essarily aligned with current dietary trends in Mediterranean-
border countries, which like most other societies are influenced
by Western diets, with convenience, fast and ultra-processed
foods [5, 6].
Purported benefits
The salutary effects of the MDwere first reported in the early
1950s by the pioneering Seven Countries Study [7], an observa-
tional analysis that reported a 2- to 3-fold lower coronary heart
disease mortality in Mediterranean countries as opposed to
northern European countries or the USA [8]. Since then,
numerous studies, meta-analyses and even a randomized con-
trolled trial have confirmed an inverse association between
adherence to the MD and cardiovascular (CV) risk [9, 10].
Further, this dietary pattern has also gained recognition in its
role for prevention of obesity or type II diabetes [11].
Evidence from observational studies
Observational studies have explored the potential benefits of
MD by analysing the adherence to such a diet. Adherence is
defined through a diet score of up to nine most-representative
items from the pyramid that are health-promoting and/or
health-harming food groups. A semi-quantification/frequency
of intake for these items results in a total score whose increase
(from 0 to a maximum of 9 points) is used in observational stud-
ies to quantify the adherence of an individual to a MD pattern
[12]. Note that in this way, the MD score is population specific.
FIGURE 1: MD pyramid.
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In other words, individuals consuming more olive oil in
Scandinavia may be considered more adherent to a MD than
those consuming less olive oil within the same Scandinavian
population. However, the absolute amount of olive oil (g/day)
consumed by this Scandinavian MD adherent population may
be very low compared with what is consumed in an Italian or
Spanish setting. Studies using this MD scoring have illustrated
the positive health implications associated with this diet. A
recent meta-analysis [9] summarized the consistency of available
literature linking adherence to an MD with health. The meta-
analysis included more than 2 million healthy subjects followed
for up to 20 years and reported strong associations between MD
and reduced incidence of cognitive diseases, overall mortality
and CV mortality. They also observed consistent reductions in
biochemical indicators (blood lipids, etc.) and an improvement
in the individual’s quality of life [13]. Adherence to the MDmay
accrue benefits up to 2 years of longer survival [13].
Evidence from randomized controlled trials
Two major well-powered trials have explored the benefits of
MD in primary and secondary prevention of CVD: The Lyon
and Heart Study [14] was a randomized secondary prevention
trial aimed at testing whether an MD may reduce the rate of
recurrence after a first myocardial infarction (MI). Included
were 423 consecutive survivors of an MI asked to either comply
with a Mediterranean-type diet or follow regular dietary advice.
Within 4 years of follow-up, the MD group had a lower rate of
MI recurrence. The Prevencion con Dieta Mediterranea
(PREDIMED) study was a multicentre randomized primary
prevention trial that included nearly 7500 subjects at high CV
risk. The trial showed that at a median follow-up of 4.8 years,
the MD groups (supplemented with a daily intake of either
extra virgin olive oil or mixed nuts) experienced a 30% CVD
risk reduction compared with a low-fat diet control group. The
CVD beneficial effects were observed together with reductions
in blood pressure, obesity prevalence, inflammation, oxidative
stress, rate of progression of the carotid intima-media thickness
and improved lipid profile, thus providing the best evidence to
bring the MD to the forefront of primary prevention of CVD in
the community [10].
ARGUMENTS IN FAVOUR OF PRESCRIBING
MEDITERRANEAN-LIKE DIETS TO PATIENTS
WITH CKD: MUCH TO WIN
We should emphasize that no single component of the MD is
responsible for the positive effects that can be attributed to this
diet. Instead, it should be attributed to the balanced overall diet-
ary pattern. Further, food plays a central role in the social and
cultural life of the Mediterranean area and qualitative elements
such as conviviality, culinary activities, physical activity, out-
door life and adequate rest strengthen the health effects of MD
[9]. Table 1 summarizes these arguments and lists current evi-
dence in both CKD and non-CKD populations.
The MD provides a healthy protein and fat intake
profile
Protein intake in the MD aligns with a controlled protein
diet for CKD (0.8 g/kg/day). An interesting aspect is the
source of protein, which in the MD comes predominantly from
vegetables, fish and white meat. Red meat and processed meats
are less often consumed, which may convey a lower amount of
dietary sodium, phosphate and potassium. Such habits have
been associated with lower CV and cancer risk in the
Table 1. Arguments in favour of prescribing MDs to patients with CKD
Features of the MD Purported benefits from non-CKD studies Purported benefits from CKD studies
Provision of a healthy protein and fat intake aligned with CKD recommendations
Predominance of vegetal and fish protein
versus meat protein
Lower cardiovascular and cancer risk [15, 16] Reduced phosphate load (lower
bioavailability)
Lower risk of incident CKD and of ESRD [17, 18] Lower mortality risk [19]
Predominance of MUFA and PUFA over
SFA
Decreased systemic inflammation and (LDL) cholesterol Decreased blood pressure, CVD risk and
inflammation [21]Lower CVD risk [20]
Favour consumption of olive oil Anti-inflammatory, antioxidant and vasculoprotective
properties [20, 22]
Ameliorates constipation in HD patients [23]
High dietary fibre intake
High fibre intake Lower blood pressure, decreased inflammation and
blood lipids. Lower CVD, cancer and mortality risk [24,
25]
Reduction of CV risk factors and uraemic
toxins
Lower risk of CKD [26] Reduced inflammation and mortality risk
[27]
Moderate carbohydrate consumption preferably whole grain
Low glycaemic index and glycaemic load Beneficial effects on glucose control, hyperinsulinaemia,
insulin resistance, blood lipids and satiety [28, 29]
Reduction of oxidative stress and inflamma-
tion [30]
Wine in moderation
Moderate wine intake Lower all-cause and cardiovascular mortality. Improved
lipoprotein metabolism, reduced inflammation and oxi-
dative stress
Reduction of oxidative stress and of inflam-
mation [31]
Lower risk of CKD progression [32]
Choice of local and eco-friendly products over processed foods
Decrease in sodium, potassium and phos-
phate load [33, 34]
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community [15, 16], but also with lower risk of incident CKD
and of end-stage renal disease (ESRD) in individuals with nor-
mal kidney function [17, 18]. In patients with manifest CKD,
the benefits of plant-based versus animal-based protein have
been little studied. Old studies addressing the impact of acute
protein loading (short-term interventions of 4–12weeks) show
no or mixed effects of protein sources on estimated glomerular
filtration rate (eGFR) change [35–37]. A problem in the inter-
pretation of those studies is that the outcome in these studies is
creatinine-based eGFR estimation, which can be affected by
protein intake. Two more recent short-term randomized con-
trolled trials (RCTs) in patients with CKD Stages 3–5 showed
that adherence to a plant-based diet as compared with a meat-
based diet was effective in maintaining serum phosphate targets
and reducing FgF23 [38, 39].
A typical MD provides 50% of the lipid-derived energy from
monounsaturated fatty acids (MUFA), 25% from polyunsatu-
rated fatty acids (PUFA) and 25% from saturated fatty acids
(SFA). Oleic acid is the main MUFA representative and is
present in extra virgin olive oil, which is also rich in polyphenols
and vitamin E, and collectively has additive anti-inflammatory,
antioxidant and vasculoprotective properties [20, 22]. Increased
olive oil consumption has been consistently associated with a
lower risk of all-cause mortality, CV mortality, CV events and
stroke in the general population and in individuals with mani-
fest CVD. Such reductions are not always observed in other
studies in which MUFA sources contemplated both animal and
plant origin [9]. The MD is also rich in n-3 PUFAs (both from
marine origin and from plants), which have hypo-
triglyceridemic, anti-inflammatory and anti-thrombotic proper-
ties [4]. Lastly, because of an often low consumption of dairy,
red meat and meat products in Mediterranean countries, SFA
intake is low, not exceeding 7–8%. This is an important point
since SFA is one of the pro-inflammatory nutrients which
favour the development of atherosclerosis, being associated with
increased blood [low-density lipoprotein (LDL)]cholesterol and
increased systolic blood pressure [40].
The MD provides a low glycaemic index and low
glycaemic load
Carbohydrates, which represent >50% of total energy
intake in most modern-style diets, feature less in MD. Nearly
all carbohydrates are from high-quality, nutrient-dense car-
bohydrates coming from fruits, vegetables, whole grains and
nuts, not refined sugars, and having a low glycaemic index
which attenuates postprandial glucose and insulin responses.
Epidemiological studies have shown that the intake of whole-
grain cereals and their products such as whole-wheat bread
are associated with a 20–30% reduction in the risk of type II
diabetes and with a strong reduction of CV events [41].
Lastly, reduction in carbohydrate intake per se, has beneficial
effects on serum lipid profile [42]. The MD is characterized
by a low glycaemic index, that is, predominance of slowly
absorbed carbohydrates in the diet. A low glycaemic index
has been shown in some studies to produce beneficial effects
on glucose control, hyperinsulinaemia, insulin resistance,
blood lipids and satiety [28, 29]. A low glycaemic index may
also be relevant for dialysis patients. In the only study
available so far, dietary glycaemic load significantly associ-
ated with markers of oxidative stress and inflammation
among 58 patients undergoing dialysis, independent of body
composition and adipocytokines [30].
The MD allows a moderate consumption of wine
Regular but moderate intake of wine duringmeals (1–2glasses/
day) is recommended in the MD pyramid. Epidemiologic studies
from geographically distant populations show that individuals
with dailymoderate wine consumption are associated with a lower
risk of all-cause and, particularly, CV mortality when compared
with individuals who abstain or who drink excess alcohol [43, 44].
The beneficial effects of red wine are thought to be due to the poly-
phenol compounds, such as resveratrol, that are found in high
concentrations in various plants, including red grapes and their
derivatives, exhibiting potent anti-inflammatory and antioxidant
activity by enhancing the expression of antioxidant enzymes [45].
Phenolic compounds in wine contribute more particularly to the
overall antioxidant effects of the MDwhen the body is under con-
ditions of low-grade inflammation and oxidative stress that occur
after a meal as result of postprandial hyperglycaemia and hyperli-
pidaemia [46]. White wine, although lacking polyphenols, con-
tains simple phenols, such as tyrosol and hydroxytyrosol, which
have similar antioxidant and anti-inflammatory properties.
Moderate wine consumption may also benefit patients with CKD.
A prospective, randomized trial studied this among 10 healthy
volunteers and 10 patients with CKD Stages 3–4. The combined
consumption, for 2weeks, of 2–3 glasses/day of white wine and
extra virgin olive oil resulted in a significant reduction of plasma
markers of chronic inflammation while no significant variation
was observed with extra virgin olive oil alone [31]. In North
European settings, alcohol consumption has been associated with
a lower risk of CKD progression [32]. The inability of that study
to differentiate wine from spirits makes our comment, though,
speculative.
The MD favours reduced inflammation and reduced
oxidative stress—the case for increased olive oil
consumption
Collectively, several characteristics of the MD (dietary fat
profile, moderate wine intake and fruit/vegetable intake)
prompt anti-inflammatory and antioxidant effects. The intake
of these nutrients and foods has been associated with the benefi-
cial effects that the MD has in reducing oxidative stress and
inflammation [47]. In the PREDIMED trial, 1 year of MD was
successful in reducing inflammatory markers ICAM-1, IL-6
and TNF-a receptors compared with baseline values and with
the placebo group. The authors also showed a strong negative
relationship between the consumption of some components of
MD (olive oil and vegetables) and CRP and IL-6 plasma con-
centrations [48]. Olive oil contains not only oleic acid, but also
abundant polyphenols that have been shown to reduce E-selec-
tin levels and improve flow-mediated vasodilation [49].
Polyphenols also exert beneficial effects on blood pressure, lip-
ids and insulin resistance. As shown by PREDIMED, the total
polyphenol intake, calculated from the sum of the polyphenol
content from different reported food items, was associated with
lower mortality risk [50]. Antioxidants also include high
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amounts of vitamin C, vitamin E, glutathione, selenium, folate
and phenolic compounds from red wine (resveratrol), coffee,
tea, nuts, herbs and spices [12]. In the Attica Study, total antiox-
idant capacity (TAC) was positively correlated with the MD
score. Participants in the highest TAC tertile had an average
19% lower oxidized LDL-cholesterol concentration than partic-
ipants in the lowest tertile. TAC was positively correlated with
the consumption of olive oil, fruits and vegetables, was inversely
associated with the consumption of red meat, and was not asso-
ciated with either cereals or whole grains intake [51]. It has
been suggested that the health-related quality of life reported by
individuals consuming an MD is strongly related to the TAC
content of the diet [52]. The potential benefits of this healthy
eating on the persistent inflammation and oxidative stress of
CKD deserve further study. A small RCT in haemodialysis
patients demonstrated that the daily use of olive oil was as effec-
tive as mineral oil in the treatment of constipation [23]
The MD favours natural versus processed foods
The traditional MD is associated with traditional, local and
eco-friendly products, with low use of processed foods. The
impact of MD is therefore not only explained by its specific
nutrients and foods, but also by the way these foods are pro-
duced, cooked and eaten [53]. Food-processing techniques can
profoundly modify nutrient content and food properties from
the crop to the table. For instance, the content of antioxidant
and phytochemicals in fruits and vegetables depends on agro-
nomic practices (fertilizer þ/, organic or conventional), ripe-
ness when harvested, post-harvest handling, storage, types of
processing, distances transported, consumption and eating pat-
terns. Food processing may affect the effects of food on health
and disease. For instance, in community-based studies it has
been observed that high red meat consumption was associated
with progressively shorter survival, largely because of the
consumption of processed red meat. Consumption of non-
processed red meat alone was not associated with shorter sur-
vival [54]. Further, processed foods contain a higher content of
sodium and phosphorus to preserve and enhance textures and
flavours, which may impact on CKD progression and its com-
plications [33]. Replacing processed foods by natural choices
has shown clear benefits in ESRD patients [34].
The MD promotes increased dietary fibre intake
The MD provides 30–50 g/day of fibre with a 1:1 ratio of
soluble to insoluble fibres. Dietary fibre has important health-
promoting properties. Besides its well-known benefits to the
gastrointestinal tract, individuals with high intakes of dietary
fibre appear to be at significantly lower risk for developing coro-
nary heart disease, stroke, hypertension, diabetes, obesity and
certain gastrointestinal diseases. Increasing fibre intake lowers
blood pressure and serum cholesterol levels, improves glycae-
mia and insulin sensitivity, and reduces inflammation [24, 25].
The MD, with its abundant supply of quality carbohydrates
(>50% whole grains) and dietary fibre, lowers glycaemic load
and increases plasma levels of anti-inflammatory adiponectin.
A NHANES III Study showed that fibre intake was low in most
individuals (14.5 g of fibre/day compared with daily recommen-
dations of 25 g/day). It also showed that high fibre intake
showed strong inverse associations with inflammation and
mortality in the subpopulations with CKD. Specifically, each
10 g/day increase in total dietary fibre intake was associated
with a 17% lower mortality risk [26]. Results were later con-
firmed in a Swedish population [55]. Finally, as phytate reduces
the bioavailability of potassium and phosphate, the rather high-
fibre content of the MD has certainly a very small impact on
mineral availability.
The beneficial effect of dietary fibre may also be linked to the
shift of gut microbial activity from a proteolytic towards a sac-
charolytic fermentation pathway. This results in a reduced gener-
ation of indoles and phenols waste products from the colonic
proteolytic fermentation, which are potential factors in vascular
inflammation and may contribute to CV and bone disease, insu-
lin resistance and accelerate the progression of renal disease [56].
In support of this a significant difference in generation rates of
two major nephrovascular toxins, indoxyl sulfate and p-cresyl
sulphate, between omnivores and vegetarians has been demon-
strated, in healthy adults, presumably owing to their different
protein and fibre profiles (i.e. higher protein/fibre ratio in omni-
vores) [27]. Furthermore, the ratio of dietary protein–fibre intake
was strongly associated with the serum concentration of these
toxins in a small study of CKD patients [57]. A high-fibre intake
relative to protein has been linked to reduced CV risk in individ-
uals with mild CKD [58]. It has been proposed that an MD style
diet, in combination with probiotic/prebiotic formulations, could
be a valid therapeutic approach for individuals with CKD [59].
ARGUMENTS AGAINST PRESCRIBING
MEDITERRANEAN-LIKE DIETS TO PATIENTS
WITH CKD: FEAR REGARDING FRUITS AND
VEGETABLES
A legitimate concern when prescribing this diet to patients with
CKD is the frequent intake of fruit and vegetables that charac-
terizes the MD. In CKD, these foods are particularly known to
be high in potassium, and are typically cautioned due to their
potential to contribute to hyperkalaemia, affect electrolyte bal-
ance and impact on serum acidity. On the other hand the cardi-
oprotective effects of the associated vitamins, fibre and
antioxidants discussed above are well-established and are
important in both CV and kidney disease prevention. This
needs to be balanced with the potential electrolyte toxicity and
therefore monitored regularly. In this section we, however,
counterbalance those arguments and revisit recent literature
suggesting further benefits of fruits and vegetables in CKD.
Table 2 summarizes these fears and lists our counterarguments
based on studies emerging from both CKD and non-CKD
populations.
The MD favours high potassium versus low sodium
intake—dangerous?
Fruits and vegetables contain potassium and are naturally
low in sodium. The intake ratio of these two electrolytes has
been implicated in blood pressure control and the risk of CV
events in the general population [60]. According to the WHO,
the dietary sodium-to-potassium ratio should be close to 1.
However, in Dietary Approaches to Stop Hypertension
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(DASH) diet, which was effective in decreasing blood pressure
levels, had targets of 2300mg and 4700mg/day for sodium and
potassium, respectively, i.e. a sodium-to-potassium ratio close
to 0.5 [70]. In the MD, the sodium-to-potassium ratio is typi-
cally in the range of 0.4–0.6 and observational studies have
indeed associated this with reduced blood pressure and CV risk
[71, 72]. Population-based studies indicate that higher potas-
sium intake, probably as a proxy of the overall beneficial effects
of fruits and vegetables, associates with lower odds of CKD
[61]. In individuals with normal renal function, higher urinary
potassium has been associated with a lower incidence of CV
complications and reduced risk of ESRD [73, 74]. These benefi-
cial results are thought to be mediated by the reduction of blood
pressure, the upregulation of renal kinins leading to the reduc-
tion of renal vascular resistance, or by the dietary antioxidants
that have anti-inflammatory activity [75]. On the basis of this
evidence, we conclude that fruit and vegetable intake may be of
benefit in primary prevention of CKD, but adequately designed
RCTs are needed to prove this.
In referred CKD patients, however, results are conflicting
and warrant caution. In the MDRD Study, urinary potassium
excretion was associated with lower risk for all-cause mortality
but not for ESRD [62]. In CRIC, urinary potassium excretion
was instead associated with increased risk of CKD progression
[63]. These issues require further study and confirmation.
Although there are multiple factors influencing urinary potas-
sium excretion beyond potassium intake in patients with CKD/
dialysis [76], we recommend that choice of fruits and vegetables
with low potassium content and close potassium monitoring
may be advocated in patients with CKD (see section on imple-
mentation of the MD in CKD patients). Pharmacological strat-
egies (such as the novel potassium binders) may favour a more
liberal consumption of these foods.
The MD impacts on dietary acid load—good or bad?
Fruits and vegetables are sources of potassium salts of
organic acids that generate bicarbonate. The MD is, therefore,
net-base- yielding and has the potential to decrease the dietary
acid load (DAL) and prevent the low-grade, subclinical meta-
bolic acidosis that typically accompanies Western diets. The
possible benefits of a low DAL in community-dwelling individ-
uals with normal renal function come from observational
studies that tend to suggest potential (modest) benefits in
reducing the incidence of diabetes, fractures, hypertension,
CVD or mortality [65, 66, 77, 78]. It has also been suggested
that low DAL associates with a reduced risk of incident CKD
[67], suggesting a potential avenue for preventing CKD through
diet. No RCTs have, to our knowledge, been performed. DAL
has recently gained attention in nephrology as manifest CKD
patients retain dietary ions and electrolytes, which influence
bodies’ pH and metabolic acidosis leading to worse outcomes.
Several observational studies report an association between
higher DAL and faster decline in kidney function [68, 69].
Based on this, it has been hypothesized that decreasing DAL
might be an effective kidney-protective therapy [79]. A small
trial of patients with early CKD confirmed that a diet rich in
fresh fruits and vegetables can lower DAL and control meta-
bolic acidosis in a comparable manner to sodium bicarbonate
[64]. No hyperkalaemia events were reported in this high-fruit
consumption intervention, attributed by the authors to the fact
that potassium was ingested together with non-chloride anions
in fruits/vegetables that facilitated urine potassium excretion
[64]. However, whether long-term DAL control can ameliorate
progression in CKD patients remains to be tested. The recent
observation [80] that dietary estimated net acid excretion
(NAE) and measured NAE (sum of urine ammonium and
titratable acidity in 24-h urine) have opposing associations with
the risk of kidney function decline brings a new degree of com-
plexity in this area. The authors proposed the novel hypothesis
that the risk of CKD progression related to low NAE or acid
load may be due to diet-independent changes in acid
production.
THE MD AND CKD—WHAT DO WE
CURRENTLY KNOW?
The favourable effects of the MD on endothelial function,
inflammation, lipid profile and blood pressure suggest that this
type of diet could be linked to better preserved renal function.
A number of studies, mostly of observational nature, have
explored possible health benefits in individuals with CKD
(Table 2). For example, observational studies from Scandinavia
reported that in community-dwelling older men, higher MD
adherence was negatively and significantly associated with the
Table 2. Arguments against prescribing MDs to patients with CKD
Features of the MD Counterarguments from non-CKD studies Counterarguments from CKD studies
High consumption of fruits and vegetables
Increased consumption of potassium; fear
of hyperkalaemia
A high potassium intake leads to better blood pres-
sure control [60]
Lower risk of mortality [62], but perhaps
higher risk of CKD progression [63]
Lower risk of incident CKD and of ESRD [61] Overall, no clear association with hyperkalae-
mia risk [64], but careful potassium monitor-
ing is advocated
Dietary acid load misbalance, favouring
low acid load
A low dietary acid load may have modest positive
effects in reducing the risk of diabetes, fractures,
hypertension and mortality [65, 66]
A low dietary acid load associates with a
slower decline in renal function [68, 69]
A low dietary acid load associates with a lower inci-
dence of CKD [67]
A low dietary acid load is effective for the
control of serum bicarbonate [64]
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risk of having CKD. During the 9.9 years follow-up, 33% of
patients with CKD died. Survival rates were significantly worse
for low-adherent participants than for those in the other two
groups [81]. Similar results were reported in the longitudinal
Northern Manhattan Study in USA, where increasing adher-
ence to an MD was associated with decreased odds of incident
CKD [82]. Also from the USA, the NIH-AARP Diet and Health
Study, including over 500 000 community-dwelling adults, aged
51–70 years, reported that a better adherence to a MD was con-
sistently associated with a reduced risk of ESRD [hazards ratio
(HR) 0.84; 95% confidence interval (CI) 0.74–0.95 per MD
score increase) [73].
Conversely to these studies, post-hoc analyses from the
PREDIMED trial do not observe any effect of MD intensifica-
tion on renal outcomes. In an analysis of 665 PREDIMED par-
ticipants, those assigned to MD had a similar eGFR decline
after 2 years than the control low-fat diet [83]. In a larger subset
of 3614 PREDIMED participants with type 2 diabetes and free
of microvascular complications at enrolment, those assigned to
an MD diet associated with a reduced incidence of diabetic ret-
inopathy, but no association was found with diabetic nephrop-
athy [84]. These discrepant findings may be partly explained by
the characteristics of PREDIMED population—healthy individ-
uals in their 50s with dyslipidaemia, where the follow-up, and
the rate of renal outcomes, albuminuria progression or eGFR
decline within 2 years may be low. Also, they were participants
from Spain, following presumably a Mediterranean-like diet.
PREDIMED actually tested the intensification of an MD in an
already MD population of middle-age range and relatively
healthy. It is possible that the MD may be more beneficial in
societies with dietary patterns more distant from this concept,
as suggested by the above-mentioned observational studies
fromNorthern Europe and USA.
Nonetheless, MD may have beneficial effects in intermediate
outcomes that associate with renal and CVD risk. A small RCT
implemented an MD in 40 participants with CKD Stage 2 in a
90-day intervention [85]; although the intervention time was not
sufficient to denote eGFR changes (which remained, as expected,
stable), the authors report a significant reduction in triglycerides,
total and LDL-cholesterol, and CRP in the MD group, improve-
ments altogether in metabolic profile that may link to some of the
mechanistic explanations mentioned above.
WHAT WOULD AN MD PRESCRIPTION LOOK
LIKE FOR A PATIENT WITH CKD?
Based on the above, practical modifications are required for
making a ‘Mediterranean-style’ diet realistic in patients with
manifest CKD in order to meet the needs of individuals pre-
scribed a specific restriction to potassium or phosphorus and
modification of protein intake and other potential permuta-
tions as detailed in Table 4. This further emphasizes the need
for close contact and support by a registered dietician
specialized in renal nutrition. Monitoring of laboratory val-
ues and patient-reported symptoms is a key strategy to safely
implement such dietary changes. In addition to nutrient con-
siderations, the potential burden on shifting dietary habits
toward incorporating a more MD approach warrants atten-
tion. CKD patients have a preference for interventions that
are tailored and supported with frequent interactions, moni-
toring and feedback, including group support [89]. Reflecting
on the intervention delivery attributes from the PREDIMED
study, a combination of individual- and group-interaction-
supported participants, and those with the greatest increase
in adherence had the worst diets at baseline [90]. However,
the supplemental food products provided, not the dietary
advice alone, resulted in the most striking changes in intakes
in PREDIMED [10, 91]. Substantial provision of extra virgin
olive oil and nuts to participants resulted in a sustained
increase in intake. The take-home message from such studies
appears to be that simple exchange and addition of food
products such as oil and nuts may support a cardioprotective
dietary profile, as an adjunct to dietary advice. Although not
formally tested in CKD patients, simplified assessment tools
Table 4. Considerations for implementing the MD in CKD
Food groups CKD diet recommendations MD Considerations for CKD
Meat and alternativesa Protein intake in the MD aligns with a controlled protein diet
(0.8 g/kg/day). Requires monitoring and may require more in
dialysis settings
Limit processed meat (high in additives of sodium, phosphate and
potassium)
Meat >50% high-biological value White 2/week
Red <2/week
Fish No specific recommendation 2/week
Legumes No specific recommendation 2/week Phosphorus content of low biological availability
Nuts No specific recommendation 1–2/day Unsalted; 30 g (small handful) is the equivalent of one meat serving
Dairy productsb MD recommends low-fat options. If phosphorus is a problem, try
non-dairy substitutes (i.e. nut-based milk)1/day 2/day
Fruit and vegetablesa Low potassium alternatives and cooking methods (boiling), if
requiredFruit 2–3 servings/day (low potassium) 1–2/main meal
Vegetables Up to 3 servings/day (low potassium) 2/main meal
Fats and oils Aim for 2–3  15mL (one tablespoon) servings per day; replace
other cooking oils with olive oilOlive oil No specific recommendation 1/main meal
Products with added sugars No specific recommendation 2/week Limit where possible. Be aware potassium and phosphate additives
are abundant in the food supply and are highly bioavailable
a1 serving ¼ 100–150 g.
b1 serving ¼ 250mL milk, 40 g cheese, 200 g yoghurt.
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can promote self-monitoring based on dietary pattern recom-
mendations. ‘Your Med Diet Score’ (http://oldwayspt.org/
sites/default/files/files/RateYourMedDietScore.pdf) is one of
such one-time assessment tools for patients to self-evaluate
their adherence to the MD. General feedback, motivational
messages and tips to increase intake to reach the amounts
recommended are provided.
CONCLUSION
A broad range of evidence suggests that an MD can substan-
tially improve or even prevent the development of several
chronic diseases, especially CVD, leading to a significant reduc-
tion of all-cause and CVmortality. A smaller number of studies
suggest similar benefits of an MD for renal health. Concerns for
hyperkalaemia risk when increasing fruit and vegetable intake
are legitimate and overall this dietary pattern requires certain
adaptations to fit current dietary recommendations for CKD.
Overall, most of this evidence comes from large observational
studies and/or small interventions in CKD patients, and in
order to move forward adequately designed intervention studies
would be needed. Unfortunately, such efforts are still lacking in
all fields of renal nutrition so far. Here we analysed the pur-
ported benefit of an MD through its salutary effects of individ-
ual constituents. While this was done for a neat argumentation
of the mechanistic pathways affected, the MD should, however,
be considered as a whole dietary pattern and, in addition, part
of a healthy lifestyle that also includes physical activity, outdoor
life and conviviality. An MD for renal patients may go beyond
its potential health impacts.
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ABSTRACT
The current therapeutic strategy for the treatment of chronic
kidney diseases only ameliorates disease progression. During
renal injury, developmental genes are re-expressed and could be
potential therapeutic targets. Among those genes reactivated in
the adult damaged kidney, Gremlin is of particular relevance
since recent data suggest that it could be a mediator of diabetic
nephropathy and other progressive renal diseases. Earlier stud-
ies have shown that Gremlin is upregulated in trans-
differentiated renal proximal tubular cells and in several chronic
kidney diseases associated with fibrosis. However, not much
was known about the mechanisms by which Gremlin acts in
renal pathophysiology. The role of Gremlin as a bone morpho-
genetic protein antagonist has clearly been demonstrated in
organogenesis and in fibrotic-related disorders. Gremlin binds
to vascular endothelial growth factor receptor 2 (VEGFR2) in
endothelial and tubular epithelial cells. Activation of the
Gremlin–VEGFR2 axis was found in several human nephropa-
thies. We have recently described that Gremlin activates the
VEGFR2 signaling pathway in the kidney, eliciting a down-
stream mechanism linked to renal inflammatory response.
Gremlin deletion improves experimental renal damage, dimin-
ishing fibrosis. Overall, the available data identify the Gremlin–
VEGFR2 axis as a novel therapeutic target for kidney inflamma-
tion and fibrosis and provide a rationale for unveiling new con-
cepts to investigate in several clinical conditions.
Keywords: diabetic nephropathy, fibrosis, Gremlin, inflamma-
tion, TGF-b1, VEGF
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